Merck to develop personalized cancer vaccine in collaboration with Moderna Ruchika Sharma13 Oct 2022 12:15 PM ISTUnder the agreement, originally established in 2016 and amended in 2018, Merck will pay Moderna $250 million to exercise its option for personalized...
Merck VS Mylan Pharma: US Court of Appeals for the Federal Circuit rules in favor of Merck in Sitagliptin Dihydrogen Phosphate patent lawsuit Ruchika Sharma2 Oct 2022 5:00 PM ISTThe ruling from the U.S. Court of Appeals provides JANUVIA, JANUMET and JANUMET XR patent protection through May 2027, which includes six (6) months...
Merck agrees to allow Sinopharm to sell COVID drug molnupiravir in China Ruchika Sharma2 Oct 2022 3:30 PM ISTNew York: Drugmaker Merck & Co said on Wednesday that it agreed to allow China's Sinopharm to distribute and import its COVID-19 antiviral...
Merck gets EMA Committee positive opinion for Pneumococcal 15-valent Conjugate Vaccine in infants, children Ruchika Sharma19 Sept 2022 5:16 PM ISTPneumococcal disease is an infection caused by the bacterium Streptococcus pneumoniae, or pneumococcus.
Merck Investigational Anticoagulant Therapy MK-2060 gets USFDA fast track designation Ruchika Sharma24 Aug 2022 11:27 AM ISTMK-2060 is a novel inhibitor of Factor XI being investigated for the prevention of thrombosis in patients with end-stage renal disease (ESRD).
USFDA says possible carcinogens found in Merck's Sitagliptin drugs Januvia, Janumet Roshni Dhar13 Aug 2022 5:39 PM ISTThe U.S. Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck's diabetes drugs Januvia and Janumet, were...
Health Bulletin 12/August/2022 Roshni Dhar12 Aug 2022 5:33 PM ISTHere are the Top Health stories for the day:Omicron is not mild for the frail, 32 deaths in Delhi in 10 daysThere have been 32 deaths in the past 10...
Merck Specialities ropes in Pratima Reddy as new MD in India Rahul Verma3 Aug 2022 3:48 PM ISTMerck India has recently announced the appointment of Pratima Reddy as the Managing Director for Merck Specialities Pvt. Ltd, the healthcare business...
Merck Healthcare business, BioMed X begin new research project in Oncology Ruchika Sharma2 Aug 2022 5:42 PM ISTGermany: BioMed X, a German independent research institute, has announced the start of its new research project 'Extrachromosomal DNA in Cancer'...
Merck Specialities appoints Pratima Reddy as new MD in India Ruchika Sharma1 Aug 2022 5:28 PM ISTNew Delhi: Merck India has recently announced the appointment of Pratima Reddy as the Managing Director for Merck Specialities Pvt. Ltd, the...
Merck Keytruda fails head and neck cancer trial Rahul Verma21 July 2022 5:00 PM ISTMerck, known as MSD outside the United States and Canada, has announced that the Phase 3 KEYNOTE-412 trial evaluating KEYTRUDA (pembrolizumab),...
Merck Keytruda fails in head and neck cancer trial Ruchika Sharma21 July 2022 2:30 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
